NCT00261534

Brief Summary

The purpose of this study is to examine the degree of fatigue in patients receiving chemotherapy. Special interest goes out to the course of fatigue throughout five treatments and the actions taken by patients to reduce this fatigue.The correlation between fatigue and haemoglobin will also be subject of study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2006

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 5, 2005

Completed
27 days until next milestone

Study Start

First participant enrolled

January 1, 2006

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2006

Completed
Last Updated

September 14, 2006

Status Verified

September 1, 2006

First QC Date

December 1, 2005

Last Update Submit

September 13, 2006

Conditions

CancerFatigue

Keywords

Chemotherapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of cancer requiring chemotherapy treatment

You may not qualify if:

  • Pregnancy
  • Psychological illness
  • Life expectancy less than three months
  • Lack of basic proficiency in Dutch

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Centre Alkmaar

Alkmaar, North Holland, 1815JD, Netherlands

Location

MeSH Terms

Conditions

NeoplasmsFatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • D. Hilarius, MSc

    Medical Centre Alkmaar, Hospital Pharmacy

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 1, 2005

First Posted

December 5, 2005

Study Start

January 1, 2006

Study Completion

July 1, 2006

Last Updated

September 14, 2006

Record last verified: 2006-09

Locations

NL(1)